Karachi: GlaxoSmithKline Pakistan Limited has electronically credited the final cash dividend for the year ended December 31, 2025, into the designated bank accounts of its shareholders. The announcement comes as a significant development for investors, reflecting the company’s financial strategies and performance over the past year.

On May 6, 2026, the pharmaceutical giant confirmed that the final cash dividend stands at Rs. 12.00 per share, equating to a 120% payout. The decision to disburse dividends in this manner aligns with the company’s commitment to providing consistent returns to its stakeholders.

According to information available from the Pakistan Stock Exchange (PSX), such a dividend represents a significant move within the designated market category. The electronic transfer of dividends underscores the efficiencies adopted by GlaxoSmithKline Pakistan Limited in ensuring timely and seamless financial transactions for its shareholders.

The dividend announcement reflects on GlaxoSmithKline Pakistan Limited’s performance and its ongoing strategy to maintain investor confidence. The company continues to be a key player within the pharmaceutical sector, contributing to the economic landscape through its operations and shareholder engagements.